US drug agency approves breakthrough treatment for pancreatic cancer
The US Food and Drug Administration has approved a treatment for pancreatic cancer that, in clinical trials, nearly doubled the overall survival time for patients.
The drug, daraxonrasib, sold under
bbc.co.uk•August 27, 2026